Chain Drug Review - Novartis’ Diovan O.K.’d for a new use
Monday, January 12th, 2009 EAST HANOVER, N.J. — The Food and Drug Administration has approved Diovan as a treatment for reducing cardiovascular deaths in patients who are at high risk after suffering a heart attack.
The regulatory agency granted Novartis Pharm…
